Reaction
Vascular Calcification reporting signals
As of the last recalculation, Vascular Calcification appears in 1,060 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 36.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 158 | 36.0 | 36.0 |
| Chlorhexidine Gluconate | 16 | 34.9 | 35.0 |
| Meperidine Hydrochloride | 12 | 25.9 | 25.9 |
| Warfarin | 134 | 23.6 | 23.6 |
| Epoetin Alfa | 13 | 21.8 | 21.8 |
| Paricalcitol | 14 | 19.7 | 19.7 |
| Melphalan | 18 | 15.8 | 15.8 |
| Ezetimibe And Simvastatin | 12 | 15.7 | 15.7 |
| Melphalan Hydrochloride | 19 | 15.1 | 15.1 |
| Amlodipine Besylate And Benazepril Hydrochloride | 7 | 15.0 | 15.0 |
| Calcitriol Capsules 0.25 Mcg | 15 | 14.9 | 14.9 |
| Calcitriol Capsules 0.5 Mcg | 15 | 14.9 | 14.9 |
| Calcitriol | 15 | 14.7 | 14.7 |
| Fondaparinux Sodium | 6 | 14.6 | 14.6 |
| Fulvestrant | 23 | 14.0 | 14.0 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 18 | 11.6 | 11.6 |
| Thalidomide | 21 | 11.4 | 11.4 |
| Nilotinib | 14 | 9.4 | 9.4 |
| Cinacalcet Hydrochloride | 10 | 4.2 | 4.2 |